138 related articles for article (PubMed ID: 36442191)
21. Silibinin inhibits in vitro ketosis by regulating HMGCS2 and NF-kB: elucidation of signaling molecule relationship under ketotic conditions.
Kang DY; Sp N; Do Park K; Lee HK; Song KD; Yang YM
In Vitro Cell Dev Biol Anim; 2019 May; 55(5):368-375. PubMed ID: 31025252
[TBL] [Abstract][Full Text] [Related]
22. Fasting-induced HMGCS2 expression in the kidney does not contribute to circulating ketones.
Venable AH; Lee LE; Feola K; Santoyo J; Broomfield T; Huen SC
Am J Physiol Renal Physiol; 2022 Apr; 322(4):F460-F467. PubMed ID: 35224990
[TBL] [Abstract][Full Text] [Related]
23. Impaired autophagy and APP processing in Alzheimer's disease: The potential role of Beclin 1 interactome.
Salminen A; Kaarniranta K; Kauppinen A; Ojala J; Haapasalo A; Soininen H; Hiltunen M
Prog Neurobiol; 2013; 106-107():33-54. PubMed ID: 23827971
[TBL] [Abstract][Full Text] [Related]
24. Specific binding of Hsp27 and phosphorylated Tau mitigates abnormal Tau aggregation-induced pathology.
Zhang S; Zhu Y; Lu J; Liu Z; Lobato AG; Zeng W; Liu J; Qiang J; Zeng S; Zhang Y; Liu C; Liu J; He Z; Zhai RG; Li D
Elife; 2022 Sep; 11():. PubMed ID: 36048712
[TBL] [Abstract][Full Text] [Related]
25. Ketogenesis contributes to intestinal cell differentiation.
Wang Q; Zhou Y; Rychahou P; Fan TW; Lane AN; Weiss HL; Evers BM
Cell Death Differ; 2017 Mar; 24(3):458-468. PubMed ID: 27935584
[TBL] [Abstract][Full Text] [Related]
26. Acetylcholinesterase Inhibitor Donepezil Effects on Plasma β-Hydroxybutyrate Levels in the Treatment of Alzheimer's Disease.
Wan L; Lu J; Fu J; Huang J; Yang Q; Xin B; Chen L; Huo Y; Zhong Y; Guo C
Curr Alzheimer Res; 2018; 15(10):917-927. PubMed ID: 29852870
[TBL] [Abstract][Full Text] [Related]
27. Keratin 8 absence down-regulates colonocyte HMGCS2 and modulates colonic ketogenesis and energy metabolism.
Helenius TO; Misiorek JO; Nyström JH; Fortelius LE; Habtezion A; Liao J; Asghar MN; Zhang H; Azhar S; Omary MB; Toivola DM
Mol Biol Cell; 2015 Jun; 26(12):2298-310. PubMed ID: 25904331
[TBL] [Abstract][Full Text] [Related]
28. Assessment of cerebrospinal fluid (CSF) beta-amyloid (1-42), phosphorylated tau (ptau-181) and total Tau protein in patients with Alzheimer's disease (AD) and other dementia at Siriraj Hospital, Thailand.
Thaweepoksomboon J; Senanarong V; Poungvarin N; Chakorn T; Siwasariyanon N; Washirutmangkur L; Udompunthuruk S
J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S77-83. PubMed ID: 21721431
[TBL] [Abstract][Full Text] [Related]
29. Regulation of Ketogenic Enzyme HMGCS2 by Wnt/β-catenin/PPARγ Pathway in Intestinal Cells.
Kim JT; Li C; Weiss HL; Zhou Y; Liu C; Wang Q; Evers BM
Cells; 2019 Sep; 8(9):. PubMed ID: 31546785
[TBL] [Abstract][Full Text] [Related]
30. Variations in the effects on synthesis of amyloid beta protein in modulated autophagic conditions.
Makioka K; Yamazaki T; Kakuda S; Okamoto K
Neurol Res; 2009 Nov; 31(9):959-68. PubMed ID: 19215663
[TBL] [Abstract][Full Text] [Related]
31. The protective effects of Esculentoside A through AMPK in the triple transgenic mouse model of Alzheimer's disease.
He Z; Zhang H; Li X; Tu S; Wang Z; Han S; Du X; Shen L; Li N; Liu Q
Phytomedicine; 2023 Jan; 109():154555. PubMed ID: 36610160
[TBL] [Abstract][Full Text] [Related]
32. KDM1A-mediated upregulation of METTL3 ameliorates Alzheimer's disease via enhancing autophagic clearance of p-Tau through m6A-dependent regulation of STUB1.
Tang Z; Cao J; Yao J; Fan X; Zhao J; Zhao M; Duan Q; Han B; Duan S
Free Radic Biol Med; 2023 Feb; 195():343-358. PubMed ID: 36587923
[TBL] [Abstract][Full Text] [Related]
33. Nuclear and cellular, micro and nano calcification in Alzheimer's disease patients and correlation to phosphorylated Tau.
Tsolaki E; Csincsik L; Xue J; Lengyel I; Bertazzo S
Acta Biomater; 2022 Apr; 143():138-144. PubMed ID: 35259518
[TBL] [Abstract][Full Text] [Related]
34. Untangling amyloid-β, tau, and metals in Alzheimer's disease.
Savelieff MG; Lee S; Liu Y; Lim MH
ACS Chem Biol; 2013 May; 8(5):856-65. PubMed ID: 23506614
[TBL] [Abstract][Full Text] [Related]
35. Co-Localization of Glia Maturation Factor with NLRP3 Inflammasome and Autophagosome Markers in Human Alzheimer's Disease Brain.
Ahmed ME; Iyer S; Thangavel R; Kempuraj D; Selvakumar GP; Raikwar SP; Zaheer S; Zaheer A
J Alzheimers Dis; 2017; 60(3):1143-1160. PubMed ID: 28984607
[TBL] [Abstract][Full Text] [Related]
36. NDP52 associates with phosphorylated tau in brains of an Alzheimer disease mouse model.
Kim S; Lee D; Song JC; Cho SJ; Yun SM; Koh YH; Song J; Johnson GV; Jo C
Biochem Biophys Res Commun; 2014 Nov; 454(1):196-201. PubMed ID: 25450380
[TBL] [Abstract][Full Text] [Related]
37. Mammalian target of rapamycin: a valid therapeutic target through the autophagy pathway for Alzheimer's disease?
Cai Z; Zhao B; Li K; Zhang L; Li C; Quazi SH; Tan Y
J Neurosci Res; 2012 Jun; 90(6):1105-18. PubMed ID: 22344941
[TBL] [Abstract][Full Text] [Related]
38. Palmitoylation of ketogenic enzyme HMGCS2 enhances its interaction with PPARalpha and transcription at the Hmgcs2 PPRE.
Kostiuk MA; Keller BO; Berthiaume LG
FASEB J; 2010 Jun; 24(6):1914-24. PubMed ID: 20124434
[TBL] [Abstract][Full Text] [Related]
39. Involvement of nutrients and nutritional mediators in mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase gene expression.
Rescigno T; Capasso A; Tecce MF
J Cell Physiol; 2018 Apr; 233(4):3306-3314. PubMed ID: 28888048
[TBL] [Abstract][Full Text] [Related]
40. Interplay between age, cerebral small vessel disease, parenchymal amyloid-β, and tau pathology: longitudinal studies in hypertensive stroke-prone rats.
Schreiber S; Drukarch B; Garz C; Niklass S; Stanaszek L; Kropf S; Bueche C; Held F; Vielhaber S; Attems J; Reymann KG; Heinze HJ; Carare RO; Wilhelmus MM
J Alzheimers Dis; 2014; 42 Suppl 3():S205-15. PubMed ID: 24825568
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
